Practice question

Answer the question and get instant feedback.

ModerateSU (C)Type 2 Diabetes Mellitus with Chronic Kidney Disease"ada standards of care (2025): pharmacologic approaches to glycemic treatment"

A 61-year-old woman with T2D and CKD (eGFR 52; UACR 200 mg/g) is on metformin. Which additional agent slows CKD progression and provides CV benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.